Plasmacytoid DCs and CD1c+ DCs are known to be reduced in the peripheral circulation of established RA patients, particularly in those with active disease, where they migrate to the synovial compartment (25–27, 29, 31, 35, 38, 72). The gene discussed is CD1C; the disease is rheumatoid arthritis.